{"id":253436,"date":"2026-01-27T02:53:06","date_gmt":"2026-01-27T02:53:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/253436\/"},"modified":"2026-01-27T02:53:06","modified_gmt":"2026-01-27T02:53:06","slug":"ai-designed-anti-crisprs-enable-rapid-cas13-inhibition","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/253436\/","title":{"rendered":"AI\u2011Designed Anti\u2011CRISPRs Enable Rapid Cas13 Inhibition"},"content":{"rendered":"<p>        <a href=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2022\/09\/Getty_922717208_CRIPSRCas13a-scaled-e1662491105114.jpg\" data-caption=\"Credit: Meletios Verras\/Getty Images\" rel=\"nofollow noopener\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" width=\"696\" height=\"363\" class=\"entry-thumb td-modal-image\" src=\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/01\/Getty_922717208_CRIPSRCas13a-scaled-e1662491105114-696x363.jpg\"   alt=\"CRIPSR-Cas13a\" title=\"getty_922717208\"\/><\/a>Credit: Meletios Verras\/Getty Images<\/p>\n<p>Last year\u2019s landmark case of \u201c<a href=\"https:\/\/www.genengnews.com\/?s=baby+kj\" target=\"_blank\" rel=\"noopener nofollow\">Baby KJ<\/a>\u201d\u2014the first patient to receive a personalized CRISPR\u2011based gene therapy\u2014showcased both the promise and the persistent challenges of genome editing. While CRISPR systems can act as remarkably precise molecular scissors, their active enzymes don\u2019t always switch off cleanly. Lingering Cas activity can nick unintended DNA or RNA targets, raising the risk of harmful mutations in healthy genes. For CRISPR to reach its full therapeutic potential, researchers need reliable ways to keep these editors in check.<\/p>\n<p>That\u2019s where anti\u2011CRISPRs come in. These phage\u2011derived proteins act as natural off\u2011switches for CRISPR\u2013Cas systems, blocking nuclease activity through mechanisms ranging from competitive inhibition to disruption of effector complex formation. But despite their utility, anti\u2011CRISPRs (Acrs) are notoriously difficult to find. In the past decade, only 118 experimentally validated Acrs have been identified\u2014an effort that could be compared to playing molecular \u201cWhere\u2019s Waldo.\u201d<\/p>\n<p>A team of researchers from Monash University and the University of Melbourne believes AI can change that. In a new study published in Nature Chemical Biology, titled \u201c<a href=\"https:\/\/www.nature.com\/articles\/s41589-025-02136-3\" target=\"_blank\" rel=\"noopener nofollow\">De novo design of potent CRISPR\u2013Cas13 inhibitors<\/a>,\u201d the group describes a rapid, AI\u2011accelerated strategy for designing entirely new anti\u2011CRISPR proteins. \u201cWe leveraged de novo protein design to create new\u2011to\u2011nature protein inhibitors of CRISPR\u2013Cas, which we call artificial intelligence (AI)-designed Acrs (AIcrs),\u201d the authors wrote.<\/p>\n<p>The team focused on Cas13a from Leptotrichia buccalis, an RNA\u2011targeting CRISPR effector for which no validated natural inhibitors exist. Using RoseTTAFold\u2011Diffusion (RFdiffusion) for protein generation and ProteinMPNN for inverse folding, the researchers computationally designed candidate inhibitors capable of binding and blocking Cas13a. They then validated these designs across a comprehensive workflow in both bacterial and human cells.<\/p>\n<p>According to lead protein designer Cyntia Taveneau, PhD, \u201cUsing AI\u2011accelerated protein design, we rapidly produced functional inhibitors of CRISPR that function in bacterial and human cells.\u201d The entire process\u2014from target selection to hit and lead identification\u2014took just eight weeks, a dramatic acceleration compared to traditional discovery\u2011based approaches.<\/p>\n<p>The speed matters because natural Acr discovery remains slow and unpredictable. \u201cThe discovery of natural inhibitors against clinically relevant targets remains challenging and time\u2011consuming,\u201d noted co\u2011author Rhys Grinter, PhD. By contrast, the AI\u2011designed inhibitors demonstrated potent and specific suppression of Cas13a nuclease activity, functioning through mechanisms consistent with their computational design.<\/p>\n<p>Anti\u2011CRISPRs typically inhibit CRISPR\u2013Cas systems by blocking crRNA or target nucleic acid binding, or preventing formation of the active effector complex. The AI\u2011designed Acrs appear to follow similar principles, but with the advantage of being engineered for a specific Cas target.<\/p>\n<p>Associate professor Gavin Knott, PhD, sees broad implications for the field. The ability to \u201cdesign bespoke inhibitors that can keep CRISPR \u2018in line\u2019 will contribute to the ongoing development of CRISPR tools in diverse applications across research, medicine, agriculture, and microbiology,\u201d he said.<\/p>\n<p>While these AI\u2011designed inhibitors are still early\u2011stage, the work demonstrates a powerful new route for expanding the CRISPR control toolbox. If CRISPR is to become a reliable therapeutic platform, precise and programmable off\u2011switches may be just as important as the editors themselves\u2014and AI may be the key to building them on demand.<\/p>\n","protected":false},"excerpt":{"rendered":"Credit: Meletios Verras\/Getty Images Last year\u2019s landmark case of \u201cBaby KJ\u201d\u2014the first patient to receive a personalized CRISPR\u2011based&hellip;\n","protected":false},"author":2,"featured_media":253437,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[27759,111,43,139,69,147],"class_list":{"0":"post-253436","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-science","8":"tag-genome-editing","9":"tag-new-zealand","10":"tag-news","11":"tag-newzealand","12":"tag-nz","13":"tag-science"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/253436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=253436"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/253436\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/253437"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=253436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=253436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=253436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}